Heart Failure Reviews

Papers
(The TQCC of Heart Failure Reviews is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome46
Comprehensive approach to cardiac amyloidosis care: considerations in starting an amyloidosis program44
Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction42
Severe low-gradient aortic stenosis: impact of inadequate left ventricular responses to high afterload on diagnosis and therapeutic decision-making41
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis32
The cardiosplenic axis: the prognostic role of the spleen in heart failure31
Right ventricular failure: a comorbidity or a clinical emergency?31
Can mechanical circulatory support be an effective treatment for HFpEF patients?28
Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction27
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris25
The role of TAVR in patients with heart failure: do we have the responses to all questions?25
Correction to: Is it time to revisit ICD indications?25
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?24
Atrial fibrillation-induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition24
Mechanisms, time course and predictability of premature ventricular contractions cardiomyopathy—an update on its development and resolution22
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review22
Clinical management of amyloid cardiomyopathy21
Cardiac 31P MR spectroscopy: development of the past five decades and future vision—will it be of diagnostic use in clinics?21
Filamin C in cardiomyopathy: from physiological roles to DNA variants20
Speckle tracking echocardiography in heart failure development and progression in patients with apneas19
Resistance training in heart failure patients: a systematic review and meta-analysis19
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers18
Advanced airway management and respiratory care in decompensated pulmonary hypertension17
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging17
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease17
0.039989948272705